Article
Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment.
Research in virology - 1 Jan 2000
Piccinino F, Felaco F M, Sagnelli E, Aprea L, Messina V, Pasquale G, Filippini P, Scolastico C
Abstract excerpt
The aims of the study were to evaluate the long-term efficacy and tolerability of different doses of interferon-alpha (IFN alpha) and different durations of treatment in chronic hepatitis C by comparing 3 or 6 mega units (MUs) three times weekly given for either 12 or 24 months, and the possibility of obtaining a response in non-responder patients by increasing the dose or by administering IFN daily. A total of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.